Hidenobu Yuki

Role of the serotonin3 receptor in stress-induced defecation.

K Miyata, Takeshi Kamato, Akito Nishida et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 112 citations

Medicine, Neurobiology, Pharmacology +17

Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.

Akito Nishida, K Miyata, Rie Tsutsumi et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 89 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

YF476 is a new potent and selective gastrin/cholecystokinin‐B receptor antagonist <i>in vitro</i> and <i>in vivo</i>

Yusuke Takinami, Hidenobu Yuki, Akito Nishida et al. · Alimentary Pharmacology & Therapeutics · 1997 · 64 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.

Mariko Yamano, Hidenobu Yuki, Shuhei Yasuda et al. · PubMed · 2000 · 58 citations

Medicine, Neuroscience, Pharmacology +17

Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.

K Miyata, Takeshi Kamato, Akito Nishida et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 55 citations

Medicine, Medicinal Chemistry, Pharmacology +14